{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T14:19:34Z","timestamp":1766067574104,"version":"build-2065373602"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012542","name":"Sichuan Province Science and Technology Support Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31870341","81673329","81871300"],"award-info":[{"award-number":["31870341","81673329","81871300"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/j.ejphar.2022.175151","type":"journal-article","created":{"date-parts":[[2022,7,13]],"date-time":"2022-07-13T11:29:47Z","timestamp":1657711787000},"page":"175151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Sis-25, a meroditerpenoid derivative with a cyclobutane scaffold, inhibits activated T cell proliferation by targeting GSK3\u03b2 in vitro and in vivo"],"prefix":"10.1016","volume":"929","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4316-8885","authenticated-orcid":false,"given":"Yang","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingren","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiuyin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xingyan","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingchao","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunfen","family":"Mo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huijie","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuxia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yantang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pematenzin","family":"Puno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Limei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ejphar.2022.175151_bib1","doi-asserted-by":"crossref","first-page":"4113","DOI":"10.1016\/S0021-9258(18)53587-0","article-title":"Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes","volume":"268","author":"Ajchenbaum","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175151_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1136\/annrheumdis-2017-211555","article-title":"Novel therapies for immune-mediated inflammatory diseases: what can we learn from their use in rheumatoid arthritis, spondyloarthritis, systemic lupus erythematosus, psoriasis, Crohn's disease and ulcerative colitis?","volume":"77","author":"Baker","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"38","key":"10.1016\/j.ejphar.2022.175151_bib3","doi-asserted-by":"crossref","first-page":"14723","DOI":"10.1074\/jbc.RA118.002800","article-title":"mTOR complex 1 controls the nuclear localization and function of glycogen synthase kinase 3 beta","volume":"293","author":"Bautista","year":"2018","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2022.175151_bib4","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.pharmthera.2014.11.016","article-title":"Glycogen synthase kinase-3 (GSK3): regulation, actions, and diseases","volume":"148","author":"Beurel","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"10","key":"10.1016\/j.ejphar.2022.175151_bib5","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.4049\/jimmunol.1203057","article-title":"Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3","volume":"190","author":"Beurel","year":"2013","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.ejphar.2022.175151_bib6","doi-asserted-by":"crossref","first-page":"5000","DOI":"10.4049\/jimmunol.1203057","article-title":"Regulation of Th1 cells and experimental autoimmune encephalomyelitis by glycogen synthase kinase-3","volume":"190","author":"Beurel","year":"2013","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.ejphar.2022.175151_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.it.2009.09.007","article-title":"Innate and adaptive immune responses regulated by glycogen synthase kinase-3 (GSK3)","volume":"31","author":"Beurel","year":"2010","journal-title":"Trends Immunol."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175151_bib8","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.4049\/jimmunol.1003511","article-title":"Glycogen synthase kinase-3 is an early determinant in the differentiation of pathogenic Th17 cells","volume":"186","author":"Beurel","year":"2011","journal-title":"J. Immunol."},{"issue":"10","key":"10.1016\/j.ejphar.2022.175151_bib9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/S1074-5521(00)00025-9","article-title":"Selective small molecule inhibitors of glycogen synthase kinase-3 modulate glycogen metabolism and gene transcription","volume":"7","author":"Coghlan","year":"2000","journal-title":"Chem. Biol."},{"issue":"7429","key":"10.1016\/j.ejphar.2022.175151_bib10","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.1038\/492S50a","article-title":"Psoriasis uncovered","volume":"492","author":"Crow","year":"2012","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.ejphar.2022.175151_bib11","doi-asserted-by":"crossref","first-page":"2971","DOI":"10.1248\/cpb.37.2971","article-title":"Imidazo[2,1-b]benzothiazoles. II. Synthesis and antiinflammatory activity of some imidazo[2,1-b]benzothiazoles","volume":"37","author":"el-Shorbagi","year":"1989","journal-title":"Chem. Pharm. Bull. (Tokyo)"},{"issue":"6","key":"10.1016\/j.ejphar.2022.175151_bib12","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1681\/ASN.V1061366","article-title":"Newer immunosuppressive drugs: a review","volume":"10","author":"Gummert","year":"1999","journal-title":"J. Am. Soc. Nephrol."},{"issue":"9","key":"10.1016\/j.ejphar.2022.175151_bib13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nm.4148","article-title":"Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus","volume":"22","author":"He","year":"2016","journal-title":"Nat. Med."},{"issue":"9","key":"10.1016\/j.ejphar.2022.175151_bib14","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S0165-6147(03)00206-2","article-title":"Lithium and GSK-3: one inhibitor, two inhibitory actions, multiple outcomes","volume":"24","author":"Jope","year":"2003","journal-title":"Trends Pharmacol. Sci."},{"issue":"16","key":"10.1016\/j.ejphar.2022.175151_bib15","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.93.16.8455","article-title":"A molecular mechanism for the effect of lithium on development","volume":"93","author":"Klein","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U.S.A."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175151_bib16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1002\/jemt.1090","article-title":"Immunopathogenesis of delayed-type hypersensitivity","volume":"53","author":"Kobayashi","year":"2001","journal-title":"Microsc. Res. Tech."},{"issue":"7","key":"10.1016\/j.ejphar.2022.175151_bib17","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/bph.14926","article-title":"PO-322 exerts potent immunosuppressive effects in vitro and in vivo by selectively inhibiting SGK1 activity","volume":"177","author":"Lai","year":"2020","journal-title":"Br. J. Pharmacol."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175151_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/nri3220","article-title":"Immunotherapy: therapeutic targeting of IL-17 for psoriasis","volume":"12","author":"Leavy","year":"2012","journal-title":"Nat. Rev. Immunol."},{"issue":"3","key":"10.1016\/j.ejphar.2022.175151_bib19","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1476-5381.2012.02172.x","article-title":"BD750, a benzothiazole derivative, inhibits T cell proliferation by affecting the JAK3\/STAT5 signalling pathway","volume":"168","author":"Liu","year":"2013","journal-title":"Br. J. Pharmacol."},{"issue":"6","key":"10.1016\/j.ejphar.2022.175151_bib20","doi-asserted-by":"crossref","first-page":"9193","DOI":"10.1002\/jcb.28195","article-title":"A benzoxazole derivative PO-296 inhibits T lymphocyte proliferation by the JAK3\/STAT5 signal pathway","volume":"120","author":"Luo","year":"2019","journal-title":"J. Cell. Biochem."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175151_bib21","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.immuni.2019.03.021","article-title":"The IL-17 family of cytokines in Health and disease","volume":"50","author":"McGeachy","year":"2019","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ejphar.2022.175151_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1042\/CS20100163","article-title":"Psoriasis: from pathogenesis to novel therapeutic approaches","volume":"120","author":"Monteleone","year":"2011","journal-title":"Clin. Sci. (Lond.)"},{"issue":"6","key":"10.1016\/j.ejphar.2022.175151_bib23","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1172\/JCI78087","article-title":"T cell signaling abnormalities contribute to aberrant immune cell function and autoimmunity","volume":"125","author":"Moulton","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175151_bib24","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1136\/annrheumdis-2017-211568","article-title":"Early and sustained efficacy with apremilast monotherapy in biological-naive patients with psoriatic arthritis: a phase IIIB, randomised controlled trial (ACTIVE)","volume":"77","author":"Nash","year":"2018","journal-title":"Ann. Rheum. Dis."},{"issue":"12","key":"10.1016\/j.ejphar.2022.175151_bib25","doi-asserted-by":"crossref","first-page":"6869","DOI":"10.4049\/jimmunol.167.12.6869","article-title":"IL-7 enhances the survival and maintains the size of naive T cells","volume":"167","author":"Rathmell","year":"2001","journal-title":"J. Immunol."},{"issue":"462","key":"10.1016\/j.ejphar.2022.175151_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau8826","article-title":"T cells take aim at a ubiquitous autoantigen in multiple sclerosis","volume":"10","author":"Sabatino","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"10","key":"10.1016\/j.ejphar.2022.175151_bib27","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1093\/ecco-jcc\/jjy085","article-title":"Peficitinib, an oral Janus kinase inhibitor, in moderate-to-severe ulcerative colitis: results from a randomised, phase 2 study","volume":"12","author":"Sands","year":"2018","journal-title":"J Crohn's Colitis"},{"issue":"12","key":"10.1016\/j.ejphar.2022.175151_bib28","doi-asserted-by":"crossref","first-page":"5638","DOI":"10.4049\/jimmunol.1200936","article-title":"IL-10 produced by induced regulatory T cells (iTregs) controls colitis and pathogenic ex-iTregs during immunotherapy","volume":"189","author":"Schmitt","year":"2012","journal-title":"J. Immunol."},{"issue":"4","key":"10.1016\/j.ejphar.2022.175151_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213831","article-title":"Glycogen synthase kinase 3-beta inhibition induces lymphangiogenesis through beta-catenin-dependent and mTOR-independent pathways","volume":"14","author":"Stump","year":"2019","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.ejphar.2022.175151_bib30","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.4049\/jimmunol.1600396","article-title":"Glycogen synthase kinase-3 modulates cbl-b and constrains T cell activation","volume":"199","author":"Tran","year":"2017","journal-title":"J. Immunol."},{"issue":"9","key":"10.1016\/j.ejphar.2022.175151_bib31","doi-asserted-by":"crossref","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","article-title":"Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis","volume":"182","author":"van der Fits","year":"2009","journal-title":"J. Immunol."},{"issue":"12","key":"10.1016\/j.ejphar.2022.175151_bib32","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/nrneph.2014.172","article-title":"Pharmacogenetics and immunosuppressive drugs in solid organ transplantation","volume":"10","author":"van Gelder","year":"2014","journal-title":"Nat. Rev. Nephrol."},{"issue":"10143","key":"10.1016\/j.ejphar.2022.175151_bib33","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S0140-6736(18)31363-1","article-title":"Baricitinib for systemic lupus erythematosus: a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"392","author":"Wallace","year":"2018","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ejphar.2022.175151_bib34","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2215\/CJN.08570814","article-title":"Immunosuppressive medications","volume":"11","author":"Wiseman","year":"2016","journal-title":"Clin. J. Am. Soc. Nephrol. : CJASN"},{"issue":"2","key":"10.1016\/j.ejphar.2022.175151_bib35","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1021\/ol303226c","article-title":"Scopariusins, a new class of ent-halimane diterpenoids isolated from Isodon scoparius, and biomimetic synthesis of scopariusin A and isoscoparin N","volume":"15","author":"Zhou","year":"2013","journal-title":"Org. Lett."},{"issue":"24","key":"10.1016\/j.ejphar.2022.175151_bib36","doi-asserted-by":"crossref","first-page":"6062","DOI":"10.1021\/acs.orglett.5b03079","article-title":"Scopariusicides, novel unsymmetrical cyclobutanes: structural elucidation and concise synthesis by a combination of intermolecular [2 + 2] cycloaddition and C-H functionalization","volume":"17","author":"Zhou","year":"2015","journal-title":"Org. Lett."},{"issue":"17","key":"10.1016\/j.ejphar.2022.175151_bib37","doi-asserted-by":"crossref","first-page":"4446","DOI":"10.1021\/ol401991u","article-title":"Scopariusic acid, a new meroditerpenoid with a unique cyclobutane ring isolated from Isodon scoparius","volume":"15","author":"Zhou","year":"2013","journal-title":"Org. Lett."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922004125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922004125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T04:19:02Z","timestamp":1762143542000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922004125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8]]},"references-count":37,"alternative-id":["S0014299922004125"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175151","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sis-25, a meroditerpenoid derivative with a cyclobutane scaffold, inhibits activated T cell proliferation by targeting GSK3\u03b2 in vitro and in vivo","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175151","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"175151"}}